Navigation Links
FDA Puts Partial Hold on Avandia Safety Study
Date:7/21/2010

WEDNESDAY, July 21 (HealthDay News) -- No new patients will be permitted to enroll in a safety study of the controversial diabetes drug Avandia until further notice, the U.S. Food and Drug Administration announced Wednesday.

But under the partial clinical trial hold, those patients already enrolled in the TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation) trial will be allowed to continue to participate, the agency said in a news release.

An FDA advisory panel last week ruled that Avandia (rosiglitazone) does boost users' heart risks, but it also decided that the drug should stay on the market because there's no definitive evidence of an increased risk.

The FDA said Wednesday that it is evaluating available data on Avandia's safety and the discussions from last week's advisory panel meeting. When the review is complete, the agency will inform the public about the findings and what they mean for the drug's status and the TIDE trial.

GlaxoSmithKline, which makes Avandia, was told by the FDA to update researchers, institutional review boards and ethics committees involved in the TIDE trial about new safety information presented at the FDA advisory panel meeting. That information can be used to update informed consent information for people already enrolled in the TIDE trial, the FDA said.

GSK agreed to conduct the TIDE trial in 2007 after concerns about the safety of Avandia first became public. The goal of the trial is to determine whether Avandia poses greater heart risks than a competing drug called Actos.

In a news release, the drug company confirmed that it will suspend enrollment of new patients in the TIDE trial and send a summary of recent safety data and a summary of the FDA advisory panel meeting to all TIDE researchers and institutional review boards.

"This pause in enrollment will give clinical trial investigators and patients time to learn about the data presented to the FD
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
2. Deep brain stimulation reduces epileptic seizures in patients with refractory partial and secondarily generalized seizures
3. Study shows partial lung removal favorable over full removal as treatment for lung cancer
4. Hip surgery success partially predicted by number of other existing conditions
5. Diabetes Drugs Avandia, Actos Tied to Fractures in Women
6. Remove Diabetes Drug Avandia From Market: FDA Reports
7. Remove Diabetes Drug Avandia From Market: FDA Documents
8. FDA Says It Hasnt Decided Whether to Pull Diabetes Drug Avandia Off the Market
9. FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market
10. Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia
11. Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Puts Partial Hold on Avandia Safety Study
(Date:11/27/2014)... Burnsville MN (PRWEB) November 27, 2014 ... manufacturer of office ergonomics equipment , has announced ... partnership with Commercial Office Environments. The partnership will ... for office furnishings location. , In addition to ... the new dealer partnership promotes HealthPostures' products with ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. ... laughter as we enjoy the ugly sweater contest." Last ... scratch. " It was a sight to see. She ... enough, the Christmas balls were faces of the staff with ... participating this year, it's simple to get in on the ...
(Date:11/27/2014)... Delhi, India (PRWEB) November 27, 2014 Ethane ... has announced it will provide a 10% Christmas discount on ... month of December. The discount offer will begin on 1 ... 2014. , About this offer, a PPC professional working ... for all, especially for small businesses, as this big discount ...
(Date:11/27/2014)... Francisco, California (PRWEB) November 27, 2014 ... his search for vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum ... leading rock bands played at the University of Alabama. ... 1969. According to Hawley, “It started with Gary Weinberger ... and working at University Programs Council. The council was ...
(Date:11/26/2014)... 27, 2014 Recently, DressVe , ... occasion dresses, has unveiled its 2014 Cyber Monday Sales. ... new dresses, up to 90 percent off. The special ... 3. Free delivery is provided for orders above $69. ... dresses, shoes, handbags and other fashion accessories. The mission ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2Health News:DressVe.com: Best 2014 Special Monday Sales Online 2
... super bug hounding them relentlessly. While patients battling diseases ... quite ‘sick’ with the alien invasion. Of particular virulence ... difficile, which networks with gusto among the NHS hospitals. ... annually is also known for its caprice and unpredictability. ...
... increasingly used to improve patient care. In a recent report the ... babies in US alone who succumb to sudden infant death syndrome ... the University of Texas has come up with a new solution ... ,Hung Cao, along with his friends developed a device that can ...
... method of blood test to diagnose Parkinson disease. This test ... the symptoms arrive. The test is done by a team ... University specialists. ,They have also created a genetic ... can screen many types of PD and monitor treatment for ...
... AVONEX(R) (Interferon beta-1a) Nurse Services program which is designed to ... continue treatment with AVONEX, the most prescribed treatment for relapsing ... with MS and as a nurse I can attest first-hand ... patients and their healthcare providers in both the treatment and ...
... nomads - the force-feeding of their girls. For to be ... ,Mothers cross sticks around the ankles and squeeze the ends ... ,That is one of forcing daughters to swallow ... end until they developed wings of fat hanging from their ...
... a simple information pamphlet to interested drinkers in the ... It is found to be a promising// public ... associated with heavy drinking, shows a new study. ... use have long been recognized as a potentially useful ...
Cached Medicine News:Health News:RFID Use can Avoid Sudden Infant Death Syndrome 2Health News:New Blood Test to Diagnose Parkinson Disease 2Health News:Multiple Sclerosis Patients to Benefit With AVONEX(R) Nurse Services Program 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 3Health News:Mailing Pamphlets can Reduce Alcohol Consumption 2
(Date:11/26/2014)...  Perrigo Company plc ("Perrigo") (NYSE: PRGO ... Healthcare Products®," today announced the closing of Perrigo,s previously ... 6,809,210 ordinary shares at a public offering price of ... option to purchase up to an additional 888,157 ordinary ... Inc., as representatives of the several underwriters. ...
(Date:11/26/2014)... ALISO VIEJO, Calif. , Nov. 26, 2014 ... today announced that the U.S. Food and Drug ... to its New Drug Application (NDA) for AVP-825. ... of low-dose sumatriptan powder delivered intranasally utilizing a ... In the Complete Response letter, and consistent with ...
(Date:11/26/2014)... , November 26, 2014 A ... of the organ protrudes through the wall of a weak ... area at birth are some of the causes of hernias. ... hiatal, femoral, and incisional. An inguinal hernia is when part ... umbilical hernia is found in the area of the umbilicus. ...
Breaking Medicine Technology:Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4
... 2011 NeurogesX, Inc. (Nasdaq: NGSX ), a ... therapies, today announced it will hold a conference call on ... PDT) to report results for its second quarter ended June ... commercial launch of Qutenza® (capsaicin) 8% patch for the management ...
... Medical Services Holdings Limited ("Concord Medical" or the "Company") ... largest network of radiotherapy and diagnostic imaging centers in ... results for the second quarter of 2011 before the ... a conference call and live webcast to discuss the ...
Cached Medicine Technology:NeurogesX to Hold Conference Call to Discuss Second Quarter 2011 Results and Provide Qutenza® Launch Update 2NeurogesX to Hold Conference Call to Discuss Second Quarter 2011 Results and Provide Qutenza® Launch Update 3Concord Medical to Announce Second Quarter 2011 Financial Results on August 16, 2011 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: